HOW NIH HOODWINKED THE COUNTRY ABOUT THE NEED FOR COVID VACCINES

HOW NIH HOODWINKED THE COUNTRY ABOUT THE NEED FOR COVID VACCINES

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

The US has been hard hit by COVID. Americans have been  treated medically according to the recommendations of NIH,  CDC and FDA. The backbone of therapy has been vaccines. Few  Americans outside of hospitals have received therapeutics drugs.  Many experts feel that repurposed therapeutic drugs should have  been the backbone of the US strategy, rather than experimental  vaccines. So far the results of “vaccines or nothing” has been far  from a total success. Safe, Cheap, FDA approved therapeutic  drugs that were available would have crushed the pandemic not  just in the US but all over the world. Instead the US has  embarked on a costly, dangerous strategy using little but  vaccines for prevention. Top virologists warn of impending  disaster unless we switch from vaccines to therapeutics. Top Virologists Warnings 

NIH has been involved in testing a number of therapeutics  including convalescent plasma and drug company products,  especially monoclonal antibodies. They sponsored Gilead’s  remdesivir for hospitalized patients and gave it an EUA...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee